The GLP-1 Revolution: From Diabetes and Obesity to Alzheimer’s and PCOS

ACS Webinars

Since GLP-1 agonists soared in popularity thanks to their powerful efficacy in diabetes and obesity, the scientific community has taken an interest in studying other potential uses for these drugs, possibly including PCOS, Alzheimer’s, Parkinson’s, addiction, liver disease, and even some types of cancer.

Join Melanie G. Cree, Physician Scientist, Pediatric Endocrinologist, and Associate Professor at the University of Colorado Anschutz and Children’s Hospital Colorado, Richard Wyse, Director of Research and Development at The Cure Parkinson's Trust, and Leila Parand, Neurobehavior Specialist of the UCLA Memory Clinic at the David Geffen School of Medicine as they focus on where the research stands and how scientists and drugmakers are discovering an increasingly broad list of applications for these drugs—and learning more about their limitations along the way.

This ACS Webinar is moderated by Caroline Hopkins, Health & Science Reporter, Precision Medicine Online and GenomeWeb and co-produced with the Science History Institute.

The Joseph Priestley Society at the Science History Institute invites monthly speakers who are leaders from a wide variety of chemical and life science companies to promote a deeper understanding of science, technology, and industry.

What You Will Learn

  • The physical chemistry of the GLP-1 molecule and the science behind why a class of drugs developed for diabetes might benefit patients with Parkinson's disease 
  • The link between diabetes and cognition and the potential role of GLP-1 agonists in Alzheimer's 
  • The available research supporting GLP-1 drugs as treatment options for women with polycystic ovary syndrome (PCOS)

Co-Produced With


What an attendee said about this ACS Webinar!

This was a very informative talk and exciting news about GLP-1 agonists. I enjoyed listening to the doctors and hearing their research prospects and the new uses and applications for this medication. Being allowed to ask questions to these minds directly is a great opportunity as well.


You belong here


Melanie G. Cree
Physician Scientist, Pediatric Endocrinologist and Associate Professor, University of Colorado Anschutz and Children’s Hospital Colorado

Richard Wyse
Director of Research and Development, The Cure Parkinson's Trust

Leila Parand 
Neurobehavior Specialist, UCLA Memory Clinic, David Geffen School of Medicine

Caroline Hopkins
Health & Science Reporter, Precision Medicine Online and GenomeWeb

Related Content